CVS/$CVS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About CVS

CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 27 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all existing business lines.

Ticker

$CVS

Primary listing

NYSE

Industry

Health Care Providers & Services

Employees

259,500

ISIN

US1266501006

CVS Metrics

BasicAdvanced
$87B
16.46
$4.19
0.60
$2.66
3.86%

What the Analysts think about CVS

Analyst ratings (Buy, Hold, Sell) for CVS stock.

Bulls say / Bears say

CVS Health raised its full-year 2025 profit forecast to $6.00–$6.20 per share, up from the previous estimate of $5.75–$6.00, indicating strong financial recovery. (reuters.com)
The company reported a first-quarter adjusted profit of $2.25 per share, surpassing the estimated $1.70, reflecting effective cost-cutting measures and improved operational efficiency. (reuters.com)
Under new CEO David Joyner, CVS has implemented strategic cost reductions and management restructuring, leading to a 15% surge in share price following better-than-expected fourth-quarter profits. (reuters.com)
CVS Health reduced employee bonuses due to lower profit levels in 2024, highlighting ongoing financial challenges despite recent improvements. (reuters.com)
The company faces increased medical costs, particularly in Medicare plans, with a record-high medical loss ratio of 95.2%, indicating higher-than-expected healthcare expenses. (reuters.com)
Activist investor Glenview Capital reduced its stake in CVS by 3.75 million shares after the company posted strong first-quarter earnings, suggesting potential concerns about the sustainability of the turnaround. (reuters.com)
Data summarised monthly by Lightyear AI. Last updated on 28 Jun 2025.

CVS Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

CVS Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CVS

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs